跳至主要内容
临床试验/NL-OMON48055
NL-OMON48055撤回不适用

A randomized controlled trial of AV junction ablation and biventricular pacing versus optimal pharmacological therapy in patients with permanent atrial fibrillation - APAF-CRT Long-term Outcome

'Nuccia e Vittore Corbella' Centrum preventie hart-en longziekten te Rapallo (Genua)0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • a) Permanent AF (> 6 months) which has been considered unsuitable for AF
  • ablation or which resulted in failed AF ablation;
  • b) Severely symptomatic (AF-related symptoms), refractory to drug therapy
  • for rate control;
  • c) QRS duration * 110 ms;
  • d) At least one hospitalization related to AF and/or heart failure in the
  • previous year (see definition in section IV. Statistical Methods and Data
  • Analysis in protocol);

排除标准

  • a) Patient is less than 18 years of age;
  • b) NYHA class IV and systolic blood pressure * 80 mmHg despite optimal
  • c) Myocardial infarction within the previous 3 months;
  • d) Previously implanted cardiac devices (pacemaker/ICD/CRT) with *5%
  • pacing function. Patients who had devices implanted that had <5% of paced beats
  • (i.e., back*up
  • pacing) can be enrolled;
  • e) Severe concomitant non-cardiac disease;
  • f) Need for surgical intervention. (Cardiac surgery is scheduled)
  • g) Patients with LVEF >50% are excluded

研究者

发起方
'Nuccia e Vittore Corbella' Centrum preventie hart-en longziekten te Rapallo (Genua)

相似试验